Martin Shkreli, boss of eye-watering price-hikers Turing Pharmaceuticals, says they’ll drop the price of Daraprim, which they acquired in August, after Aids patients got a bit too loudly.
“Look, they’re Aids patients – always whining about something. OK, if going from under £10 to almost £500 in a month was a bit sudden, we’ll drop it a little. We can crank it up again later. Because we’re shits.”